Xtant Change In Cash from 2010 to 2024

XTNT Stock  USD 0.36  0.01  2.86%   
Xtant Medical Change In Cash yearly trend continues to be comparatively stable with very little volatility. Change In Cash is likely to outpace its year average in 2024. From the period from 2010 to 2024, Xtant Medical Change In Cash quarterly data regression had r-value of (0.31) and coefficient of variation of (1,317). View All Fundamentals
 
Change In Cash  
First Reported
2008-12-31
Previous Quarter
854 K
Current Value
1.6 M
Quarterly Volatility
3.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Xtant Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xtant Medical's main balance sheet or income statement drivers, such as Interest Expense of 5.3 M, Total Revenue of 53.7 M or Gross Profit of 34 M, as well as many indicators such as Price To Sales Ratio of 1.4, Dividend Yield of 0.0 or PTB Ratio of 2.49. Xtant financial statements analysis is a perfect complement when working with Xtant Medical Valuation or Volatility modules.
  
Check out the analysis of Xtant Medical Correlation against competitors.

Latest Xtant Medical's Change In Cash Growth Pattern

Below is the plot of the Change In Cash of Xtant Medical Holdings over the last few years. It is Xtant Medical's Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xtant Medical's overall financial position and show how it may be relating to other accounts over time.
Change In Cash10 Years Trend
Slightly volatile
   Change In Cash   
       Timeline  

Xtant Change In Cash Regression Statistics

Arithmetic Mean(548,045)
Geometric Mean2,041,822
Coefficient Of Variation(1,317)
Mean Deviation4,703,467
Median277,692
Standard Deviation7,219,411
Sample Variance52.1T
Range30.6M
R-Value(0.31)
Mean Square Error50.9T
R-Squared0.09
Significance0.27
Slope(492,908)
Total Sum of Squares729.7T

Xtant Change In Cash History

2024-13.9 M
2023-14.6 M
20222.1 M
202116 M
2020-2.9 M
2019-1.6 M
20183.9 M

About Xtant Medical Financial Statements

Xtant Medical shareholders use historical fundamental indicators, such as Change In Cash, to determine how well the company is positioned to perform in the future. Although Xtant Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Xtant Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Xtant Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Change In Cash-14.6 M-13.9 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Xtant Stock Analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.